Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDEdwards Lifesciences Corp Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 18 | $0.67 | $0.74 | $0.73 |
| Q2 2026 | 17 | $0.72 | $0.80 | $0.75 |
| Q3 2026 | 7 | $0.74 | $0.76 | $0.75 |
| Q4 2026 | 7 | $0.73 | $0.75 | $0.74 |
| Q1 2027 | 7 | $0.77 | $0.80 | $0.79 |
| Q2 2027 | 7 | $0.82 | $0.85 | $0.83 |
| Q3 2027 | 10 | $0.82 | $0.85 | $0.84 |
| Q4 2027 | 7 | $0.82 | $0.85 | $0.84 |
Edwards Lifesciences Corp Earnings Date And Information
Edwards Lifesciences Corp last posted its earnings results on Tuesday, February 10th, 2026. The company reported $0.58 earnings per share for the quarter, missing analysts' consensus estimates of $0.619 by $0.039. The company had revenue of 1.57 B for the quarter and had revenue of 6.07 B for the year. Edwards Lifesciences Corp has generated $2 earnings per share over the last year ($1.83 diluted earnings per share) and currently has a price-to-earnings ratio of 42.84. Edwards Lifesciences Corp has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Edwards Lifesciences Corp Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 02/10/2026 | Q4 2025 | $0.62 | $0.16 | -0.46 | $1.55 B | $1.57 B |
| 11/05/2025 | Q3 2025 | N/A | $0.50 | N/A | $1.50 B | $1.55 B |
| 08/06/2025 | Q2 2025 | N/A | $0.57 | N/A | $1.49 B | $1.53 B |
| 05/06/2025 | Q1 2025 | N/A | $0.61 | N/A | $1.40 B | $1.41 B |
| 02/28/2025 | Q4 2024 | N/A | $0.65 | N/A | $1.36 B | $1.39 B |
| 11/06/2024 | Q3 2024 | N/A | $5.14 | N/A | $1.54 B | $1.35 B |
| 07/31/2024 | Q2 2024 | N/A | $0.61 | N/A | $1.65 B | $1.39 B |
| 04/29/2024 | Q1 2024 | N/A | $0.58 | N/A | $1.57 B | $1.33 B |
| 02/12/2024 | Q4 2023 | N/A | $0.61 | N/A | N/A | $1.27 B |
| 10/27/2023 | Q3 2023 | N/A | $0.63 | N/A | N/A | $1.24 B |
| 07/28/2023 | Q2 2023 | N/A | $0.51 | N/A | N/A | $1.30 B |
| 04/28/2023 | Q1 2023 | N/A | $0.56 | N/A | N/A | $1.46 B |
| 02/13/2023 | Q4 2022 | N/A | $0.65 | N/A | N/A | $1.35 B |
| 10/28/2022 | Q3 2022 | N/A | $0.55 | N/A | N/A | $1.32 B |
| 07/29/2022 | Q2 2022 | N/A | $0.65 | N/A | N/A | $1.37 B |
| 04/28/2022 | Q1 2022 | N/A | $0.60 | N/A | N/A | $1.34 B |
| 02/14/2022 | Q4 2021 | N/A | $0.54 | N/A | N/A | $1.33 B |
| 10/29/2021 | Q3 2021 | N/A | $0.55 | N/A | N/A | $1.31 B |
| 07/30/2021 | Q2 2021 | N/A | $0.79 | N/A | N/A | $1.38 B |
| 04/28/2021 | Q1 2021 | N/A | $0.54 | N/A | N/A | $1.22 B |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Edwards Lifesciences Corp Earnings: FAQ's
The conference call for Edwards Lifesciences Corp's latest earnings report can be listened to online.
The conference call transcript for Edwards Lifesciences Corp's latest earnings report can be read online.
Edwards Lifesciences Corp (:EW) has a recorded annual revenue of $6.07 B.
Edwards Lifesciences Corp (:EW) has a recorded net income of $1.07 B.Edwards Lifesciences Corp has generated $1.84 earnings per share over the last four quarters.
Edwards Lifesciences Corp (:EW) has a price-to-earnings ratio of 42.84 and price/earnings-to-growth ratio is -2.04.